Specialized R&D Services DUCK FLATS Pharma offers highly specialized drug development consulting, focusing on non-clinical and clinical pharmacology, making it an ideal partner for biotech and pharmaceutical companies seeking expertise in mechanism of action, efficacy, and pharmacokinetics for regulatory approvals.

Recent Industry Partnership The recent collaboration with Oragenics to support FDA IND readiness and clinical trial design indicates an active engagement in innovative therapeutic areas, presenting opportunities to target emerging biotech firms in need of expert regulatory and clinical development support.

Growth Potential With revenues estimated between $10 million and $25 million and a small team of 2 to 10 employees, DUCK FLATS is positioned as a boutique provider of specialized services, offering flexible and dedicated solutions for growing and mid-stage biotech companies.

Tech-Driven Approach Utilizing a modern tech stack including Microsoft 365 and web optimization tools, DUCK FLATS maintains an efficient digital presence, enabling streamlined communication and potential for expanding its outreach within the pharmaceutical R&D sector.

Market Focus Targeting the competitive pharmaceutical and biotech consulting market, DUCK FLATS can leverage its niche expertise to attract clients involved in early-stage drug development, particularly those preparing for IND and NDA submissions, which are high-value, ongoing opportunities for sales growth.